News & Events

News & Events

Press Releases

September 09, 2026
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
September 08, 2026
Encoded Therapeutics Presents Updated Data from POLARIS Phase 1/2 Trials of ETX101 Gene Therapy in Dravet Syndrome at the 16th European Epilepsy Congress
September 02, 2026
Encoded Therapeutics to Present New Data on ETX101 Gene Therapy for Dravet Syndrome at the 16th European Epilepsy Congress
View All Press Releases

Media Kit

Logo

Media Kit - Logos

Leadership Photos

Kartik Ramamoorthi, Ph.D.
Kartik Ramamoorthi, Ph.D.
Encoded Co-Founder, CEO and Board Member
Stephanie Tagliatela
Stephanie Tagliatela
Encoded Co-Founder, Chief Scientific Officer and Board Member
Salvador Rico, M.D., Ph.D.
Salvador Rico, M.D., Ph.D.
Encoded Chief Medical Officer

Photos

Encoded lab coat
Encoded lab coat
Encoded Therapeutics headquarters in South San Francisco
Encoded Therapeutics headquarters in South San Francisco
Scientists in Encoded’s sequencing lab
Scientists in Encoded’s sequencing lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Scientist in Encoded’s lab
Download Photo Archive

Video Footage

Media Kit - Footage